01 · The Question
Does ethics approval automatically expire after one year?
Researchers often hear a simple rule: ethics approval lasts twelve months. Submit an annual progress report, renew the approval, and repeat until the study ends.
That rule describes some ethics systems and some research, but it is not universal.
Current requirements can depend on the jurisdiction, regulatory framework, research category, risk, committee determination, and institutional policy. Some studies require annual or more frequent continuing review. Some under the U.S. 2018 Common Rule no longer require routine continuing review unless the IRB determines otherwise. Other committees explicitly place approved projects on annual review cycles.
The correct answer therefore comes from your approval documentation and the rules governing your particular study, not from a universal anniversary rule.
03 · What You Need to Know
The familiar annual-review rule is no longer universal
Research ethics oversight has changed over time, and advice based on older rules can now be misleading.
Under the pre-2018 U.S. Common Rule, IRBs generally conducted continuing review at intervals appropriate to the degree of risk but at least annually. OHRP's older continuing-review guidance therefore discusses annual approval periods, expiration dates, and lapses in approval.
The revised U.S. Common Rule changed that for substantial categories of research. Under the 2018 Requirements, continuing review is generally not required for research eligible for expedited review, research reviewed through limited IRB review, or research that has progressed to certain stages such as data analysis or accessing follow-up clinical data, unless the IRB determines otherwise.
FDA requirements, research governed by other regulations, institutional policy, and ethics systems outside the United States may differ. Never assume that a colleague's study follows the same continuing-review rules as yours.
Some ethics committees still use defined annual review cycles
WHO regional ethics procedures provide a clear example of another model. The WHO Western Pacific Region Research Ethics Review Committee states that an approved proposal planned to extend beyond one year is reviewed 12 months after initial approval unless the committee determines that more frequent review is needed. It also places responsibility on the principal investigator to ensure timely review so data collection is not interrupted.
IARC's ethics procedures similarly state that approved research is kept under review and that this normally involves annual progress reports, while also allowing the committee to exempt some studies from annual reporting depending on their characteristics.
These examples reinforce the central point: the responsible committee defines the continuing oversight applicable to the research within its remit.
Risk can affect how frequently review occurs
Where periodic continuing review is required, annual review may be a maximum interval rather than a guaranteed interval.
OHRP's written-procedures guidance discusses IRB procedures for determining which projects require review more often than annually and suggests factors such as study risk, uncertainty about risk, participant vulnerability, investigator experience, projected enrollment, and novel therapies.
WHO's regional procedures likewise permit more frequent review when the committee determines it is necessary.
A higher-risk or rapidly evolving study may therefore receive a shorter review interval than a relatively stable low-risk project.
Continuing review is not simply administrative renewal
Where continuing review applies, its purpose is not merely to extend a date in a database.
The committee may need current information about participant enrollment, withdrawals, adverse events, protocol deviations, new findings, amendments, risk-benefit information, complaints, consent documents, study status, and other developments relevant to whether the research should remain approved.
OHRP's compliance guidance emphasizes that continuing review must be substantive and meaningful when it is required.
The study being renewed should therefore be the study actually being conducted, not the version remembered from the original application.
The effective date and the expiration date are not always calculated the way you expect
Approval dates can become technically complicated when initial approval is conditional or continuing review occurs before an existing approval period ends.
OHRP's guidance, for example, explains that for initial approval with conditions, the effective date may be the date when the designated reviewer determines that the conditions have been satisfied. Subsequent continuing-review dates under the older annual-review framework can follow different calculation rules.
You do not need to reverse-engineer these calculations if your committee provides the controlling dates. Record the dates it assigns.
An amendment usually does not automatically restart the approval clock
Researchers sometimes assume that approval of a protocol amendment gives the study another full year.
That is not necessarily true. Under OHRP's older continuing-review framework, review of a protocol change ordinarily did not alter the date by which continuing review was required because continuing review concerned the full protocol, not merely the modification.
Your committee may have different rules. Check the revised approval documentation after any amendment rather than calculating a new expiration date yourself.
The investigator is usually responsible for watching the deadline
Ethics offices may send reminders, but relying on them is risky.
OHRP's continuing-review guidance places responsibility on investigators to provide continuing-review information in time for the IRB to complete review before expiration and describes reminder notices as a courtesy.
WHO regional procedures likewise state that the principal investigator should ensure timely review to avoid interruption in data collection.
Put the deadline in the research calendar when approval is issued, not when the reminder email eventually appears.
Submit early enough for review, not merely before the deadline
If approval expires on 30 June, submitting a renewal application at 11:57 p.m. on 30 June may satisfy your personal definition of "before the deadline" while leaving the committee no time to review it.
Where continuing approval is required, the relevant issue may be whether the committee completes the required review before the current authorization expires.
OHRP's older guidance explicitly states that investigators should submit the necessary information in sufficient time for continuing review and reapproval to occur before expiration.
Follow your committee's recommended submission window.
There may be no grace period
Under the pre-2018 HHS framework addressed by OHRP's continuing-review guidance, there is no regulatory grace period allowing research to continue beyond the expiration date merely because renewal materials were submitted or review is almost complete.
Do not generalize that exact regulatory rule to every ethics system, but do not assume a grace period exists either. Verify what happens when your study reaches its approval end date.
Approval can continue to carry reporting requirements even without annual continuing review
The absence of routine annual continuing review does not mean the research has escaped ethics oversight.
Under the U.S. 2018 Common Rule, research that does not require continuing review remains subject to requirements concerning proposed changes and other oversight provisions. An IRB may also determine that continuing review is required for a particular study.
Similarly, committees may require progress reports, safety reporting, amendment review, or closure reporting independently of a conventional annual renewal cycle.
Do not keep an approval open indefinitely when the research is finished
Ethics committees commonly have procedures for study closure or final reporting.
The point at which a study can be closed depends on what research activities remain. Recruitment may have ended while identifiable data analysis continues. Participant interventions may be complete while follow-up remains active.
Check the committee's definition of study completion before submitting a closure report. Once a study is formally closed, additional research activities may require new authorization.
Watch Out
Do not rely on the statement "ethics approval lasts one year" unless that is actually what your approval and governing rules say. Current review requirements can differ substantially by regulatory framework and study category.
07 · A Quick Checklist
Track the life of your ethics approval
After ethics approval is issued, check:
Whether the study has a defined approval period, expiration date, continuing-review date, or another oversight schedule.
Whether routine continuing review is actually required under the regulatory framework and committee determination applicable to your study.
Whether review is annual or more frequent because of risk or another committee determination.
How far in advance continuing-review or renewal materials should be submitted.
What progress, safety, enrollment, deviation, amendment, or other information must be included when review is required.
Whether an amendment changed the approval period or left the existing deadline unchanged.
What reporting and amendment obligations continue even if routine continuing review is not required.
When and how the study should be formally closed once research activities are complete.
